Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists
  4. 286 - After putting the NOC/c boxed statement on the front cover, can additional related statements go on the inside of the APS - or does it all have to appear on the front cover?
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

286 - After putting the NOC/c boxed statement on the front cover, can additional related statements go on the inside of the APS - or does it all have to appear on the front cover?

Scheduled Pinned Locked Moved Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists
1 Posts 1 Posters 314 Views 1 Watching
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    I think you are referring to the base fair balance (correct me if I am mistaken). The base fair balance may appear inside of the booklet. Of course, there are times when a specific claim on the cover triggers the need for a particular element of the fair balance to be presented on the cover (i.e. copy-specific balance). As of July 2013, the PAAB code will require content setting the boundaries of patient selection from the Indication and Clinical Use section of the product monograph to be presented on the first surface containing drug claims. This requirement is already in place for new products, but it will apply to all healthcare product advertising reviewed by PAAB as of July 1st 2013. If this information is already conveyed in the NOC/c box, there is no need to repeat it.

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups